Relation of nutrients and hormones in polycystic ovary syndrome

被引:37
作者
Kasim-Karakas, Sidika E.
Cunningham, Wendy M.
Tsodikov, Alex
机构
[1] Univ Calif Davis, Div Endocrinol Clin Nutr & Vasc Med, Dept Internal Med, Sacramento, CA 95817 USA
[2] Univ Michigan, Dept Biostat, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[3] Calif State Univ Sacramento, Dept Nutr Family & Consumer Sci, Sacramento, CA 95819 USA
关键词
polycystic ovary syndrome; PCOS; whey protein; adrenal steroids; ghrelin;
D O I
10.1093/ajcn/85.3.688
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Insulin resistance, infertility, and hirsutism, common characteristics of polycystic ovary syndrome (PCOS), improve with even modest weight loss. Optimal dietary treatment for PCOS is not known. Objective: We compared the effects of acute protein administration with those of glucose challenges on hormones related to obesity and insulin resistance (ie, cortisol and insulin), hirsutism [ie, dehydroepiandosterone (DHEA) and androstenedione], and hunger (ie, ghrelin). Design: Patients with PCOS (n = 28; aged 26 +/- 2y) were tested with a 5-h oral-glucose-tolerance test (OGTT) and a euvolemic, euenergetic protein challenge. Results: Glucose ingestion caused larger fluctuations in blood glucose and more hyperinsulinemia than did protein (P < 0.01, overall treatment-by-time interaction). During the protein challenge, cortisol and DHEA declined over 5 h. During OGTT, cortisol and DHEA increased after the third hour and began to show significant divergence from protein from the fourth hour (P <= 0.01). During OGTT, 18 patients who had a blood glucose nadir of < 69 mg/dL had elevated cortisol (baseline: 10.4 +/- 0.4; nadir: 5.9 +/- 0.1; peak: 12.7 +/- 0.9 mu g/dL) and DHEA (baseline: 15.6 +/- 1.3; nadir: 11.2 +/- 1.0; peak: 24.6 +/- 1.6 ng/mL) (P < 0.01), whereas the remaining 10 patients with a glucose nadir of 76 +/- 2 mg/dL had no increase in adrenal steroids. Both glucose and protein suppressed ghrelin (from 935 +/- 57 to 777 +/- 51 pg/mL and from 948 +/- 60 to 816 +/- 61 pg/mL, respectively). After glucose ingestion, ghrelin returned to baseline by 4 h and increased to 1094 +/- 135 pg/mL at 5 h. After the protein challenge, ghrelin remained below the baseline (872 +/- 60 pg/mL) even at 5 h. The overall treatment effect was highly significant (P < 0.0001). Conclusions: Glucose ingestion caused significantly more hyperinsulinemia than did protein, and it stimulated cortisol and DHEA. Protein intake suppressed ghrelin significantly longer than did glucose, which suggested a prolonged satietogenic effect. These findings provide mechanistic support for increasing protein intake and restricting the simple sugar intake in a PCOS diet.
引用
收藏
页码:688 / 694
页数:7
相关论文
共 60 条
[1]   Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis [J].
Azziz, R ;
Black, V ;
Hines, GA ;
Fox, LM ;
Boots, LR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2317-2323
[2]  
BACHMAN JM, 2004, PRIM CARE UPDATE OB, V8, P12
[3]  
Blom WAM, 2006, AM J CLIN NUTR, V83, P211
[4]   Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans [J].
Broglio, F ;
Gottero, C ;
Prodam, F ;
Destefanis, S ;
Gauna, C ;
Me, E ;
Riganti, F ;
Vivenza, D ;
Rapa, A ;
Martina, V ;
Arvat, E ;
Bona, G ;
van der Lely, AJ ;
Ghigo, E .
CLINICAL ENDOCRINOLOGY, 2004, 61 (04) :503-509
[5]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[6]   Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups [J].
Chang, WY ;
Knochenhauer, ES ;
Bartolucci, AA ;
Azziz, R .
FERTILITY AND STERILITY, 2005, 83 (06) :1717-1723
[7]  
CLIFTON PM, 2003, ASIA PAC J CLIN NU S, V12, P10
[8]   Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet [J].
Crosignani, PG ;
Colombo, M ;
Vegetti, W ;
Somigliana, E ;
Gessati, A ;
Ragni, G .
HUMAN REPRODUCTION, 2003, 18 (09) :1928-1932
[9]   Minireview: Glucocorticoids - Food intake, abdominal obesity, and wealthy nations in 2004 [J].
Dallman, MF ;
La Fleur, SE ;
Pecoraro, NC ;
Gomez, F ;
Houshyar, H ;
Akana, SF .
ENDOCRINOLOGY, 2004, 145 (06) :2633-2638
[10]   Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment [J].
DeUgarte, CM ;
Bartolucci, AA ;
Azziz, R .
FERTILITY AND STERILITY, 2005, 83 (05) :1454-1460